Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity.
Front Immunol. 2022 Jul 26;13:930945. doi: 10.3389/fimmu.2022.930945. eCollection 2022.
Front Immunol. 2022.
PMID: 35958589
Free PMC article.
Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo.
Kolkhir P, Pyatilova P, Ashry T, Jiao Q, Abad-Perez AT, Altrichter S, Vera Ayala CE, Church MK, He J, Lohse K, Metz M, Scheffel J, Türk M, Frischbutter S, Maurer M.
Kolkhir P, et al. Among authors: ashry t.
J Allergy Clin Immunol. 2022 Jun;149(6):1998-2009.e5. doi: 10.1016/j.jaci.2022.02.021. Epub 2022 Mar 10.
J Allergy Clin Immunol. 2022.
PMID: 35283140
Item in Clipboard
Novel intragraft regulatory lymphoid structures in kidney allograft tolerance.
Rosales IA, Yang C, Farkash EA, Ashry T, Ge J, Aljabban I, Ayyar A, Ndishabandi D, White R, Gildner E, Gong J, Liang Y, Lakkis FG, Nickeleit V, Russell PS, Madsen JC, Alessandrini A, Colvin RB.
Rosales IA, et al. Among authors: ashry t.
Am J Transplant. 2022 Mar;22(3):705-716. doi: 10.1111/ajt.16880. Epub 2021 Dec 3.
Am J Transplant. 2022.
PMID: 34726836
Free article.
Item in Clipboard
Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer.
Gunda V, Gigliotti B, Ashry T, Ndishabandi D, McCarthy M, Zhou Z, Amin S, Lee KE, Stork T, Wirth L, Freeman GJ, Alessandrini A, Parangi S.
Gunda V, et al. Among authors: ashry t.
Int J Cancer. 2019 May 1;144(9):2266-2278. doi: 10.1002/ijc.32041. Epub 2019 Jan 24.
Int J Cancer. 2019.
PMID: 30515783
Free article.
Item in Clipboard
Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer.
Gunda V, Gigliotti B, Ndishabandi D, Ashry T, McCarthy M, Zhou Z, Amin S, Freeman GJ, Alessandrini A, Parangi S.
Gunda V, et al. Among authors: ashry t.
Br J Cancer. 2018 Nov;119(10):1223-1232. doi: 10.1038/s41416-018-0296-2. Epub 2018 Oct 17.
Br J Cancer. 2018.
PMID: 30327563
Free PMC article.
Item in Clipboard
Cite
Cite